biotech
Daiichi Sankyo posts 'extraordinary loss' of nearly $1B
Endpoints News
May 11, 2026 · 22s listen
Listen · Endpoints News
Daiichi Sankyo posts 'extraordinary loss' of nearly $1B
0:00-0:22
Live · Kokoro-82M
Audio pre-rendered by Storyflo · cached + delivered from the edge
Daiichi Sankyo is scrapping plans to build antibody-drug conjugate manufacturing capacity and recorded an "extraordinary loss" of 149.4 billion Japanese yen ($950 million) after overpromising demand for its ADCs to third-party manufacturers. The Japanese company ...
Share
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to Endpoints News.
Heard via Storyflo
Get audio versions of every article you read.
Pick what matters — your audio curator gets you into your daily flo.